Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods-Reference-Cited by-同舟云学术

Comparison of the MHC I Immunopeptidome Repertoire of B-Cell Lymphoblasts Using Two Isolation Methods

Published:2018-04-24 Issue:12 Volume:18 Page:1700251
ISSN:1615-9853
Container-title:PROTEOMICS
language:en
Short-container-title:Proteomics

Author:

Lanoix Joël¹,Durette Chantal¹,Courcelles Mathieu¹,Cossette Émilie¹,Comtois-Marotte Simon¹,Hardy Marie-Pierre¹,Côté Caroline¹,Perreault Claude¹²³,Thibault Pierre¹⁴

Affiliation:

1. Institute for Research in Immunology and Cancer

2. Department of Medicine

3. Institute for Research in Immunology and Cancer; Université de Montréal; Montreal Quebec Canada

4. Institute for Research in Immunology and Cancer; Université de Montréal; Montréal Québec Canada

Funder

Canadian Cancer Society Research Institute

Genome Canada

Genome Quebec

Canadian Institutes of Health Research

Canadian Center of Excellence in Commercialization and Research

Canadian Foundation for Innovation

Fonds de Recherche du Québec-Santé

Publisher

Wiley

Subject

Molecular Biology,Biochemistry

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pmic.201700251/fullpdf

Reference40 articles.

1. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules

2. Re-evaluating the Generation of a “Proteasome-Independent” MHC Class I-Restricted CD8 T Cell Epitope

3. Antigen Presentation and the Ubiquitin‐Proteasome System in Host–Pathogen Interactions

4. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway

5. Pathways of Antigen Processing

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the dynamic landscape of immunopeptidomics: Unravelling posttranslational modifications and navigating bioinformatics terrain;Mass Spectrometry Reviews;2024-08-16

2. Immunogenicity of Non-Mutated Ovarian Cancer-Specific Antigens;Current Oncology;2024-05-30

3. Identifying major histocompatibility complex class II-DR molecules in bovine and swine peripheral blood monocyte-derived macrophages using mAb-L243;Vaccine;2024-05

4. Characterization of antigen presentation capability for neoantigen-based products using targeted LC-MS/MS method;Journal of Pharmaceutical and Biomedical Analysis;2024-03

5. Discovery of T Cell Epitopes for Cancer Immunotherapy;Interdisciplinary Cancer Research;2024